biopartnering, page-7

The real money in biotech is made to be in early before rerating ann is announced.
This is uncomfortable as it involves lengthy research, heaps of patience and a radar for indicators to interpret anns which are riddled with confidentiality restrictions.

Waiting for clearification before investing in biostock lets you lose the stellar like profits one can make within this sector.


If your own research does not bring satisfactory results regarding this coy, its time to move to "greener" pastures.